Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 16

2338P - The phenotype of tumor-associated macrophages in human high-grade serous ovarian carcinoma

Date

21 Oct 2023

Session

Poster session 16

Topics

Tumour Immunology;  Pathology/Molecular Biology;  Molecular Oncology;  Cancer Research

Tumour Site

Ovarian Cancer

Presenters

Irina Larionova

Citation

Annals of Oncology (2023) 34 (suppl_2): S1190-S1201. 10.1016/S0923-7534(23)01928-2

Authors

I. Larionova1, E.O. Kazakova1, P. Iamshchikov1, M. Rakina1, J. Kzhyshkowska2

Author affiliations

  • 1 Lab. Of Translational Cellular And Molecular Biomedicine, National Research Tomsk State University, 634050 - Tomsk/RU
  • 2 Institute Of Transfusion Medicine And Immunology, Institute For Innate Immunoscience (mi3), Medizinische Fakultät Mannheim der Universität Heidelberg, 68167 - Mannheim/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 2338P

Background

Ovarian cancer (OC) is one of the most common gynecological cancers, with the worst prognosis and the highest mortality rate. According to the FIGO, the overall five-year survival rate is approximately 50%. Tumor-associated macrophages (TAMs) are one of the most prominent populations of immune cells in both ovarian cancer tissue and malignant ascites. The most relevant task is to identify TAM subpopulations in ovarian cancer, to discover how they interact with chemotherapy and affect the development and outcome of the disease.

Methods

Patients with high-grade serous ovarian carcinoma were included in the study. FFPE samples with tumor were obtained after surgery. The study was carried out according to medical ethics. We applied two technologies of spatial transcriptomics for the analysis of TAM transcriptomic features in patients with ovarian cancer – 10x Genomics Visium and Nanostring GeoMX-DSP. All procedures were performed according to manufacturer`s protocols.

Results

The results of 10x Visium demonstrated that TAM cluster express CCL18, APOC1, GPNMB, LYZ, APOE, C1QC, C1QB, CTCB, SPP1, CTSS, and other genes. Interestingly, according to accumulating data the expression of these macrophage markers is distinctive feature for the potentially targeted population of lipid-associated TAMs. The morphology of macrophages in TAM cluster in clinical samples corresponds to the large lipid-associated TAMs. Nanostring technology allowed us to analyse ROIs with immune cells located in different tumor sites. The transcriptome of TAMs located near the tumor nest correlated to functional activation of extracellular matrix organization, antigen presentation, vascular development and myeloid leukocyte activation. These TAMs have the same morphology of large foamy macrophages and express APOE, SPP1, LYZ, CTSS, and other genes.

Conclusions

We found gene signature specific for the large TAMs in tumor tissue of patients with high-grade serous ovarian carcinoma.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Russian Science Foundation research project No 21-75-10021.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.